First quarter sales, operating income and EPS at high-end of previously announced preliminary results Provides second quarter guidance and reaffirms […]
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
CAMBRIDGE, Mass., June 05, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]